Citius Pharmaceuticals

Patent cliffs & loss of exclusivity

Citius Pharmaceuticals is a pharmaceutical company dedicated to the development and commercialization of therapeutic products.

Company

CAGE Code8LA71
Legal NameCitius Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/citius-pharmaceuticals
Facebook URLhttps://www.facebook.com/pages/Citius-Pharmaceuticals/125252154197427
Full Address11 Commerce Drive, First Floor Cranford, NJ 07016, USA
LinkedIn URLhttps://www.linkedin.com/company/citius-pharmaceuticals-inc
Pitchbook URLhttps://pitchbook.com/profiles/company/107499-07

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. SUPRENZAPHENTERMINE HYDROCHLORIDESmall mol.Mar 2029
  2. SUPRENZAPHENTERMINE HYDROCHLORIDESmall mol.Mar 2029
  3. SUPRENZAPHENTERMINE HYDROCHLORIDESmall mol.Mar 2029

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.